Skip to main content
BrainCited

Chemotherapy-Related Cognitive Impairment
Chemotherapy-Related Cognitive Impairment

有病率: Reported by 17-75% of cancer patients undergoing chemotherapy

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'condition\u003Dchemo\u002Dbrain'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    






    
    

        
        

        
        
        

            

  
About





            {# Filter order is load-bearing: escape (untrusted text) -> linebreaks
               (paragraphs) -> paper anchors (internal /papers/ links) -> glossary
               (never links inside an existing ). #}
            

                
Cognitive dysfunction associated with cancer chemotherapy, affecting memory, attention, and processing speed. May persist for months to years after treatment.

            

        

        

        
        
        

            

  
Common Symptoms





            

                
                Memory difficulties
                
                Trouble concentrating
                
                Difficulty multitasking
                
                Slower processing speed
                
                Word-finding difficulty
                
            

        

        

        
        
        

            

  
Risk Factors





            
    
                
                
  • 
                    
                    Chemotherapy regimen type and duration
                
    • 
                
                
  • 
                    
                    Radiation therapy to the brain
                
    • 
                
                
  • 
                    
                    Older age at treatment
                
    • 
                
                
  • 
                    
                    Pre-existing cognitive difficulties
                
    • 
                
                
  • 
                    
                    Anemia during treatment
                
    • 
                
            

        

        

        
        
        

            

  
Frequently Asked Questions





            

                
                

                    
                        How is the evidence for Chemotherapy-Related Cognitive Impairment supplements graded?
                        
                    
                    

                        We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
                    

                

                
                

                    
                        What are common symptoms of Chemotherapy-Related Cognitive Impairment?
                        
                    
                    

                        Common symptoms associated with Chemotherapy-Related Cognitive Impairment include Memory difficulties, Trouble concentrating, Difficulty multitasking, Slower processing speed, Word-finding difficulty. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.
                    

                

                
            

        

        

        
        

        
        
    


    
    










    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。